FeesSafety
Pluang+

Eurozone central banks' gold repatriations haven't reduced their U.S. dollar reserve holdings significantly.

Market News
10 Nov 2026, 18:24 WIB
Kitco
View Source
Neutral
Eurozone central banks' gold repatriations haven't reduced their U.S. dollar reserve holdings significantly.

Recent relocations of gold reserves by the Netherlands, France, and Germany have not led to major declines in their U.S. dollar foreign exchange reserves, according to Federal Reserve economist Colin Weiss. Despite moving gold out of U.S. custody, these central banks continue to hold most of their reserves in U.S. dollar assets, valuing the economic benefits over potential sanctions risks. Weiss also highlights that the rise in gold prices is mainly driven by private demand, not central bank purchases, and that most gold reserves are legacy holdings from the Bretton Woods era rather than new strategic diversification away from the dollar. U.S. Treasury securities remain a key part of global reserve portfolios despite some shifts in reserve compositions.

Gold reserve repatriations and central bank reserve compositions provide context for Pluang's Financials sector snapshot. For readers following this sector, as of Nov 10, 2026 22:31 WIB, out of 142 priced US Financial stocks, 54 rose and 87 fell. Notably, AVAT rose 15.45% with 91% buy orders, MARA increased 13.10% with 76% buy orders, while UPST declined 7.80% despite 100% buy orders, showing contrasting investor behaviors and price movements within the sector.

More News

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...

Others
Bullish
1 hour ago
Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...

Bullish
1 hour ago
New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...

Others
Bullish
2 hours ago
Global nucleic acid labeling market to hit $2.8B by 2032, driven by genomics and diagnostics growth.

Global nucleic acid labeling market to hit $2.8B by 2032, driven by genomics and diagnostics growth.

The global nucleic acid labeling market, valued at $1.7 billion in 2025, is projected to grow to $2.8 billion by 2032 at a 7% CAGR. Growth is fueled by advances in genomics, molecular diagnostics, and personalized medicine, with increasing demand for...

Market News
Bullish
2 hours ago
MonetizeMore launches AI tool to help publishers avoid Google AdSense bans.

MonetizeMore launches AI tool to help publishers avoid Google AdSense bans.

MonetizeMore introduced the AdSense Policy Grader, an AI-powered tool that audits websites for compliance with Google's ad policies to prevent account bans and revenue loss. The tool offers a free basic report and a detailed paid report covering 79 p...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App